Rimas Vincas Lukas

  • 730 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Dr. Lukas, sub-specializing in neuro-oncology, is interested in the care of patients with primary brain tumors and spinal cord tumors as well as central nervous system (CNS) metastases. Dr. Lukas's research centers on clinical trials in neuro-oncology. Additionally, he has a strong interest in medical education in the U.S. and internationally and conducts research in neuroscience medical education.

Training Experience

2003Internship, Cook County Hospital, Chicago
2006Residency, University of Chicago Hospitals
2008Fellowship, University of Chicago

Education/Academic qualification

MD, Rush University

… → 2002

Research interests

  • Brain Cancer / Nervous System Cancer
  • Medical Education
  • Neuro-Oncology
  • Spinal Cord Tumors
  • Spinal Oncology

Fingerprint Dive into the research topics where Rimas Vincas Lukas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Leptomeningeal metastasis from solid tumors

Thakkar, J. P., Kumthekar, P., Dixit, K. S., Stupp, R. & Lukas, R. V., Apr 15 2020, In : Journal of the Neurological Sciences. 411, 116706.

Research output: Contribution to journalReview article

  • A Report from the 2017 Sino-US Medical Education Symposium in Wuhan, China

    Lukas, R., Jiang, I., Lio, J., Cooper, B., Dong, H., Fan, J. & Sherer, R., Jan 1 2019, In : Education for Health: Change in Learning and Practice. 32, 2, p. 99-100 2 p.

    Research output: Contribution to journalLetter

    Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study

    Gadgeel, S. M., Lukas, R. V., Goldschmidt, J., Conkling, P., Park, K., Cortinovis, D., de Marinis, F., Rittmeyer, A., Patel, J. D., von Pawel, J., O'Hear, C., Lai, C., Hu, S., Ballinger, M., Sandler, A., Gandhi, M. & Fehrenbacher, L., Feb 2019, In : Lung Cancer. 128, p. 105-112 8 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma (Nature Medicine, (2019), 25, 3, (462-469), 10.1038/s41591-019-0349-y)

    Zhao, J., Chen, A. X., Gartrell, R. D., Silverman, A. M., Aparicio, L., Chu, T., Bordbar, D., Shan, D., Samanamud, J., Mahajan, A., Filip, I., Orenbuch, R., Goetz, M., Yamaguchi, J. T., Cloney, M., Horbinski, C., Lukas, R. V., Raizer, J., Rae, A. I., Yuan, J. & 7 others, Canoll, P., Bruce, J. N., Saenger, Y. M., Sims, P., Iwamoto, F. M., Sonabend, A. M. & Rabadan, R., Jun 1 2019, In : Nature Medicine. 25, 6, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • 2 Scopus citations

    Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017)

    Zhai, L., Ladomersky, E., Lauing, K. L., Wu, M., Scholtens, D. M., Savoor, R., Zhang, B., Wu, J. D., Horbinski, C., Lukas, R. V., Binder, D. C. & Wainwright, D. A., Mar 4 2019, In : OncoImmunology. 8, 3, 1548242.

    Research output: Contribution to journalComment/debate